Keywords: ADHA market, Generic erosion, Decision Resources, Shire, Adderall, Vyvanse, Intuniv

Generic erosion will see ADHD drug market fall from $5 billion in 2009 to $4.1 billion in 2019

Article | 07 December 2010

Print This

The attention-deficit hyperactivity disorder (ADHD) drug market in the top seven countries (the USA, France, Germany, Italy, Spain, the UK ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in